The benefits, costs and feasibility of a low incidence COVID-19 strategy.
Thomas Czypionka, Emil N. Iftekhar, Barbara Prainsack, Viola Priesemann, Simon Bauer, André Calero Valdez, Sarah Cuschieri, Enrico Glaab, Eva Grill, Jenny Krutzinna, Christos Lionis, Helena Machado, Carlos Martins, George N. Pavlakis, Matjaž Perc, Elena Petelos, Martyn Pickersgill, Alexander Skupin, Eva Schernhammer, Ewa Szczurek, Sotirios Tsiodras, Peter Willeit, Paul Wilmes
Topics & Concepts
Incidence (geometry)HarmPandemicCoronavirus disease 2019 (COVID-19)BusinessEnvironmental healthDevelopment economicsMedicineEconomicsPolitical scienceDiseaseInfectious disease (medical specialty)LawPhysicsPathologyOpticsCOVID-19 epidemiological studiesLong-Term Effects of COVID-19COVID-19 Clinical Research Studies